Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice

Fig. 5

The effects of MSC injection on hepatic functional injury. A, B Representative images of HE-stained liver sections of the indicated groups. Scale bar = 50 μm. Hepatocellular ballooning in the liver of the indicated groups were scored. MET, metformin. After the last time of cell injection, serum concentrations of C AST, D ALT, E AST/ALT ratio, and F ALP were measured. The results are expressed as the means ± S.E.M. n = 6 mice per group. *P<0.05, **P<0.01, ***P<0.001 versus the vehicle group. One-way ANOVA

Back to article page